Showing results (261-270 of 379) with videos related to
Sort By:
Pageof 38
Journal of Hypertension|May 21, 2010
Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trialToshiharu Ninomiya, Sophia Zoungas, Bruce Neal, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 14, 2014
A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the Handling Erythropoietin Resistance With Oxpentifylline (HERO) trialDavid W Johnson, Elaine M Pascoe, Sunil V Badve, et al.Diabetes, Obesity & Metabolism|December 17, 2016
Comparison of exposure response relationship of atrasentan between North American and Asian populationsHiddo J L Heerspink, Hirofumi Makino, Dennis Andress, et al.Clinical Kidney Journal|February 10, 2021
Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes: the CARMELINA randomized controlled trialChristoph Wanner, Mark E Cooper, Odd Erik Johansen, et al.Clinical Pharmacology and Therapeutics|December 18, 2020
Individual Atrasentan Exposure is Associated With Long-term Kidney and Heart Failure Outcomes in Patients With Type 2 Diabetes and Chronic Kidney DiseaseJeroen V Koomen, Jasper Stevens, George Bakris, et al.Journal of the American Society of Nephrology : JASN|October 1, 2020
Early Change in Albuminuria with Canagliflozin Predicts Kidney and Cardiovascular Outcomes: A PostHoc Analysis from the CREDENCE TrialMegumi Oshima, Brendon L Neuen, JingWei Li, et al.Clinical Journal of the American Society of Nephrology : CJASN|July 9, 2015
Predictors of Atrasentan-Associated Fluid Retention and Change in Albuminuria in Patients with Diabetic NephropathyDonald E Kohan, Hiddo J Lambers Heerspink, Blai Coll, et al.Clinical Journal of the American Society of Nephrology : CJASN|July 8, 2021
Effect of Hemodiafiltration on the Progression of Neuropathy with Kidney Failure: A Randomized Controlled TrialAmy Kang, Ria Arnold, Martin Gallagher, et al.Diabetes, Obesity & Metabolism|February 7, 2018
Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathyHiddo J L Heerspink, Dennis L Andress, George Bakris, et al.Diabetes, Obesity & Metabolism|April 1, 2018
Baseline characteristics and enrichment results from the SONAR trialHiddo J L Heerspink, Dennis L Andress, George Bakris, et al.Pageof 38